Welcome to our dedicated page for Delek US Holdings SEC filings (Ticker: DK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Delek US Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Delek US Holdings's regulatory disclosures and financial reporting.
Delek US Holdings amended its asset-based lending credit facility, increasing revolving loan commitments from $1,100.0 million to $1,250.0 million. The amendment also extends the Revolving Facility maturity from October 26, 2027 to April 9, 2031, reduces interest margins by 0.25%, and adjusts various covenant thresholds.
The amendment revises the incremental facility so Delek can expand available revolving borrowings by up to the greatest of $750.0 million, 100% of EBITDA, or adjusted plus suppressed availability, subject to conditions. The facility continues to be secured by first‑priority liens on substantially all tangible and intangible assets, with customary covenants and a minimum Fixed Charge Coverage Ratio of 1.00 to 1.00 when excess availability falls below set levels.
Delek US Holdings, Inc. director William J. Finnerty reported an open-market sale of 5,000 shares of Common Stock at $47.50 per share. The transaction was made pursuant to a Rule 10b5-1 trading plan. After this sale, he directly holds 36,369 shares.
Joseph Finnerty filed a Form 144 reporting dispositions of Common stock. The filing lists sales in March 2026: a $227,500 sale of 5,000 shares on 03/18/2026 and a $230,508 sale of 5,392 shares on 03/04/2026. The record also lists 5,000 Restricted Stock Units dated 06/10/2017 as the securities to be sold.
Delek US Holdings Inc: The Vanguard Group filed Amendment No. 10 to Schedule 13G/A reporting Amount beneficially owned: 0 and Percent of class: 0% in the issuer's Common Stock.
The filing states Vanguard completed an internal realignment on January 12, 2026 and, in accordance with SEC Release No. 34-39538, certain subsidiaries will report beneficial ownership separately going forward.
Delek US Holdings director Zohar Shlomo sold 7,343 shares of common stock in an open-market transaction at $46.00 per share. The sale occurred on March 19, 2026 and was executed under a pre-arranged Rule 10b5-1 trading plan. After this transaction, Shlomo directly holds 6,646 Delek US shares.
Director Ezra Uzi Yemin reported open-market sales totaling 55,356 shares of Delek US Holdings, Inc. common stock on March 18, 2026. The trades were executed at weighted average prices of $43.73 and $44.20 per share, across price ranges from $43.07 to $44.48.
After these sales, Yemin holds 228,419 shares directly and 569,651 shares indirectly through Yemin Investments, LP. The transactions were made under a pre-arranged Rule 10b5-1 trading plan, which indicates the timing was scheduled in advance rather than opportunistic.
Delek US Holdings director William J. Finnerty sold 5,000 shares of Common Stock in an open-market transaction at $45.50 per share. After the sale, he directly holds 41,369 shares. The transaction was executed under a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
DK filed a Form 144 reporting proposed sales of Common Stock through Fidelity Brokerage Services LLC on 03/19/2026. The filing lists recent open-market dispositions by Shlomo Zohar: 03/04/2026 7,343 shares for $315,749.00, 03/05/2026 22,029 shares for $987,633.50, and 03/09/2026 5,000 shares for $207,325.00.
The form also lists previously vested restricted stock awards with vesting dates and share counts (examples include 873 shares vested 06/10/2020 and 1,562 shares vested 12/10/2020), provided as background on the securities involved.
Ezra Uzi Yemin and affiliated Yemin Investments LP reported sales of Common stock. The filing shows Yemin Investments LP sold 66,511 shares on 03/04/2026 and Ezra Uzi Yemin sold 18,139 shares on 03/04/2026. The transactions are reported on a Form 144 as transfers of previously acquired compensation shares.
DK reports insider sales of Common Stock by Yemin-related holders. The filing shows Yemin Investments LP sold 66,511 shares and Ezra Uzi Yemin sold 18,139 shares, both reported as sold on 03/04/2026. The transactions are reported on Form 144 and reflect dispositions of issuer common stock.